MYRIAD GENETICS INC (MYGN) 8-K filings
- Ticker
- MYGN (Nasdaq)
- SEC CIK
- 899923
- Industry (SIC)
- 2835 In Vitro & In Vivo Diagnostic Substances
- Incorporated in
- DE
- All filings
- SEC EDGAR
Recent 8-Ks
| Accepted (ET) | Form | Items | Filing |
|---|---|---|---|
| 2026-11-09 16:01 | 8-K | 5.02 Executive or director change | Details |
| 2026-11-05 09:04 | 8-K | 8.01 Other events | Details |
| 2026-11-04 16:07 | 8-K | 2.02 Earnings release | Details |
| 2026-10-20 08:36 | 8-K | 1.01 Material agreement7.01 Reg FD disclosure | Details |